Skip to content
Home
Docs
Parameter
Laboratory Tests
Factor Assays PT-Based (1-Stage)
Factor Assays PT-Based (1-Stage)
Factors V, VII, X and II (Prothrombin)
Related items
Analytical Information :
4
Minimum citrate tube fill volume for routine coagulation testing
Comparison of two statistical software programs for determining reference intervals of screening coagulation assays
Analytical performance specifications for hemostasis parameters
The effect of Rivaroxaban on haemostasis assays; results from ECAT surveys
Cases :
6
Effect of high haematocrit levels on coagulation testing
A patient with acquired factor X deficiency and metastatic carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumours?
Isolated acquired factor VII deficiency: Report of Two Cases and Review of the Literature
Acquired factor X deficiency
Lupus Anticoagulant-Hypoprothrombinemia Syndrome
Factor V Inhibitor
ECAT Documents :
28
External quality assessment of the manual tilt tube technique for prothrombin time testing: a report from the IFCC-SSC/ISTH Working Group on the Standardization of PT/INR
Thromboplastin
PT-Prothrombin Time and Prothrombin Time Ratio
Prothrombin (FII)
Phospholipids
Hemostasis
Factor X (FX)
Factor VII (FVII)
Factor V (FV)
Extrinsic Pathway of Coagulation
Coumarin
Common Pathway of Coagulation
Coagulation Factors
Coagulation Cascade
Coagulation (Clotting)
International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents
Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
The results of the workshop on inhibitor testing
Algoritm for Laboratory Investigations in Case of a prolonged APTT
Is therapeutic quality influenced by choice of thromboplastin?
Measurement of new oral anticoagulans
Factor VIII inhibitor testing – a way to comparable test results
Pre-analytical Variables in the Hemostasis Laboratory
Developmental haemostasis: consequences for clinical practice
The use of snake venoms in the coagulation laboratory
When Haemostasis Assays Mislead
Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands
Guidelines :
2
ICSH recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests
Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies (ICSH)
Haemostatic Cascade :
6
TF Pathway (Extrinsic) with Common Pathway (PT)
Intrinsic Pathway APTT
Coagulation Pathways (All Components)
Activation of TAFI by Thrombin
Activation of Protein C by Thrombin
Activation of Platelets by Thrombin
Quality Issues :
1
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications
Surveys and Studies :
2
Emicizumab pilot study, part II
Emicizumab pilot study, part I
Questions or suggestions?
Clotpedia Support Form
Submit
Success
